Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;29(5):697-710.
doi: 10.1111/wrr.12925. Epub 2021 May 10.

Recent advances in the induced pluripotent stem cell-based skin regeneration

Subholakshmi Choudhury  1   2 , Nidhi Surendran  1 , Amitava Das  1   2
Affiliations
Review

Recent advances in the induced pluripotent stem cell-based skin regeneration

Subholakshmi Choudhury et al. Wound Repair Regen. 2021 Sep.

Erratum in

Abstract

Skin regeneration has been a challenging clinical problem especially in cases of chronic wounds such as diabetic foot ulcers, and epidermolysis bullosa-related skin blisters. Prolonged non-healing wounds often lead to bacterial infections increasing the severity of wounds. Current treatment strategies for chronic wounds include debridement of wounds along with antibiotics, growth factors, and stem cell transplantation therapies. However, the compromised nature of autologous stem cells in patients with comorbidities such as diabetes limits the efficacy of the therapy. The discovery of induced pluripotent stem cell (iPSC) technology has immensely influenced the field of regenerative therapy. Enormous efforts have been made to develop integration-free iPSCs suitable for clinical therapies. This review focuses on recent advances in the methods and reprogramming factors for generating iPSCs along with the existing challenges such as genetic alterations, tumorigenicity, immune rejection, and regulatory hurdles for the clinical application of iPSCs. Furthermore, this review also highlights the benefits of using iPSCs for the generation of skin cells and skin disease modeling over the existing clinical therapies for skin regeneration in chronic wounds and skin diseases.

Keywords: chronic wound healing; induced pluripotent stem cells (iPSCs); regulatory hurdles; skin disease modeling; skin regeneration.

PubMed Disclaimer

References

REFERENCES

    1. Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B. Skin wound healing process and new emerging technologies for skin wound care and regeneration. Pharmaceutics. 2020;12(8):735. https://doi.org/10.3390/pharmaceutics12080735.
    1. Guogienė I, Kievišas M, Varkalys K, Braziulis K, Rimdeika R. Split-thickness skin grafting using grafts of different thickness. Eur J Plast Surg. 2018;41(5):583-590. https://doi.org/10.1007/s00238-018-1424-1.
    1. Park JW, Hwang SR, Yoon IS. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules (Basel, Switzerland). 2017;22(8):1259. https://doi.org/10.3390/molecules22081259.
    1. Glicksman MA. Induced pluripotent stem cells: the most versatile source for stem cell therapy. Clin Ther. 2018;40(7):1060-1065. https://doi.org/10.1016/j.clinthera.2018.06.004.
    1. Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36-45. https://doi.org/10.7150/ijms.21666.

Publication types

LinkOut - more resources